GlassScriptPhysician profile
Geoffrey E Stoker
NPI 1326458779
$21,176.36
in general payments reported to CMS, 2019-2025
13 companies · $8,352 in 2025
The $8,352 reported for 2025 was more than what 86% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $263 · 2020: $2,385 · 2021: $1,932 · 2022: $146 · 2023: $712 · 2024: $7,385 · 2025: $8,352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Travel and Lodging: $2,722 · Food and Beverage: $2,472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,255.91 |
| Travel and Lodging | $2,722.17 |
| Food and Beverage | $2,471.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $11,724.62 | 2019-2025 | Attune, Actis |
| Smith+Nephew, INC. | $3,650.40 | 2020-2024 | Journey II, Or3o Dual Mobility, Legion Revision |
| Zimmer Biomet Holdings, INC. | $2,696.67 | 2020-2025 | Persona, G7, Arcos |
| Encore Medical, LP | $1,562.83 | 2020 | |
| Stryker Corporation | $859.12 | 2019-2025 | Mako, Triathlon |
| Medacta USA, INC. | $239.08 | 2023 | Gmk Sphere, M-Vizion, Gmk Efficiency |
| Orthalign INC | $146.17 | 2021 | |
| Depuy Synthes Products, INC. | $145.27 | 2024 | Velys |
| Biocomposites INC | $57.61 | 2021 | |
| Ethicon US, LLC | $28.92 | 2019 | |
| Pacira Therapeutics, INC. | $26.42 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $22.71 | 2021 | |
| Celgene Corporation | $16.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Geoffrey Stoker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.